This proposal concerns itself primarily with the possibility of using concordant xenografts of isolated pancreatic islets or crude pancreatic digests in reversing diabetes mellitus in spontaneously diabetic and streptozotocin-induced diabetic animal models. The following methods will be used to induce islet xenograft acceptance by the diabetic host: 1) direct UV irradiation of isolated islets and of crude pancreatic digests; 2) the effect of pre- and post-transplant treatment of the host with UV irradiated donor-specific blood components; 3) a combination of (1) and (2); and 4) additional peritransplant treatment of the host with a brief course of immunosuppression, particularly Cyclosporin. In the second part of this proposal the primary issue addressed is the possibility of using crude islet preparations in isografts, allografts and xenografts, rather than isolated islets, in order to avoid the problems of low yield and insufficient islet isolation that makes clinical usefulness of pancreatic islet transplantation still relatively impractical. In vitro studies of the depletion of 'stimulating cells' from the graft and the role of such cells in the xenograft model will be investigated in parallel with the above studies. The goal of this proposal is to develop a method of pretransplant treatment of the donor islet cells and of the diabetic host, which will result in 1) donor-specific prolonged xenograft survival; 2) avoidance of standard immunosuppression post-grafting; 3) retention of host immunocompetence to other antigens; and 4) clarification of mechanisms involved in the effect of UV irradiation on islet xenografts acceptance. The proposed studies are expected to demonstrate that UV irradiation will be effective in altering the immunogenicity of pancreatic islets or crude islet preparations in xenograft models. The use of the methods outlined in this proposal may have major clinical applicability to pancreatic islet transplantation in man since 1) they involve the use of xenogeneic islet tissue which could obviate the problem of supply of donor islets in clinical transplantation; 2) they involve either direct treatment of the graft or of donor type blood components, neither of which has any toxicity to the diabetic host; and 3) they may lead directly to initial trials of islet allografts and particularly concordant xenografts in man, where the methods outlined in this proposal would be readily applicable and safe, and have already been successful in induction and maintenance of islet allografts in some models of diabetes in rodents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK034232-05
Application #
3232563
Study Section
Surgery and Bioengineering Study Section (SB)
Project Start
1984-07-01
Project End
1992-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
5
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Schools of Medicine
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Oluwole, S F; Chowdhury, N C; Jin, M X (1994) The relative contribution of intrathymic inoculation of donor leukocyte subpopulations in the induction of specific tolerance. Cell Immunol 153:163-70
Chowdhury, N C; Fawwaz, R A; Oluwole, S F (1993) Induction of donor-specific tolerance to rat cardiac and small bowel allografts by intrathymic inoculation of donor T-cells. J Surg Res 54:368-74
Chowdhury, N C; Jin, M X; Hardy, M A et al. (1993) Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells. Transplant Proc 25:475-6
Chowdhury, N C; Jin, M X; Oluwole, S F (1993) Prevention of graft-versus-host disease in rat small bowel transplantation by recipient pretreatment with UV-B-modulated bone marrow cells. Transplantation 55:1229-35
Oluwole, S F; Engelstad, K; James, T (1993) Prevention of graft-versus-host disease and bone marrow rejection: kinetics of induction of tolerance by UVB modulation of accessory cells and T cells in the bone marrow inoculum. Blood 81:1658-65
Oluwole, S F; Chowdhury, N C; Fawwaz, R et al. (1993) Induction of specific unresponsiveness to rat cardiac allografts by pretreatment with intrathymic donor major histocompatibility complex class I antigens. Transplant Proc 25:299-300
Jin, M X; Chowdhury, N C; James, T et al. (1993) Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells. Transplant Proc 25:291
Oluwole, S F; Jin, M X; Chowdhury, N C et al. (1993) Induction of specific unresponsiveness to rat islet allografts by intrathymic UVB donor spleen cells. Transplantation 56:1142-7
James, T; Jin, M X; Chowdhury, N C et al. (1993) Tolerance induction to rat islet allografts by intrathymic inoculation of donor spleen cells. Transplantation 56:1148-52
Gundlach, M; Oluwole, S F; D'Agati, V et al. (1992) Differential effects of pretreatment with ultraviolet-B modified or unmodified donor-specific leukocyte transfusions on intestinal and cardiac allograft survival in the rat. Transplantation 53:613-9

Showing the most recent 10 out of 24 publications